openPR Logo
Press release

Dry Age-Related Macular Degeneration Patient Pool Analysis Market Projected to Grow at 6.9% CAGR

09-23-2025 01:07 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Dry Age-Related Macular Degeneration Patient Pool Analysis Market

Dry Age-Related Macular Degeneration Patient Pool Analysis Market

Introduction
Dry age-related macular degeneration (Dry AMD) is a chronic, progressive eye disorder that damages the macula-the central portion of the retina responsible for sharp, straight-ahead vision. Unlike wet AMD, which involves abnormal blood vessel growth, dry AMD is characterized by the accumulation of drusen (yellow deposits) beneath the retina and gradual thinning of macular tissues. While it progresses more slowly, Dry AMD accounts for nearly 85-90% of all AMD cases globally, making it the dominant form of the disease.

The growing prevalence of Dry AMD is directly tied to aging populations and lifestyle risk factors such as smoking, hypertension, and poor diet. With no definitive cure, patient management relies heavily on early diagnosis, lifestyle interventions, supportive therapies, and ongoing monitoring. As the patient pool expands worldwide, the Dry AMD patient pool analysis market is gaining momentum, driven by increasing awareness, innovation in retinal imaging, and investment in drug development pipelines.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72296

Market Overview
• Market Size (2024): USD 9.8 billion
• Forecast (2034): USD 19.2 billion
• CAGR (2024-2034): ~6.9%

Key Highlights:
• Dry AMD affects hundreds of millions of people worldwide, with prevalence rising sharply after the age of 60.
• Expanding diagnostic infrastructure, especially optical coherence tomography (OCT), enhances early detection.
• Growing clinical research into complement inhibitors, antioxidants, and regenerative therapies.
• Lifestyle and nutrition-based interventions (AREDS formulations) remain widely recommended for early-stage patients.

Leading Players: Novartis, Apellis Pharmaceuticals, Genentech/Roche, Bayer, Regeneron, Iveric Bio (Astellas), Bausch + Lomb, and several AI-driven ophthalmic imaging startups.
Key Drivers: Expanding patient pool, rising elderly populations, and advances in imaging and therapy development.
Key Challenges: Lack of curative treatment, high costs of advanced therapies, and underdiagnosis in emerging regions.

Segmentation Analysis
By Product
• Nutritional Supplements (AREDS formulations, antioxidants, vitamins)
• Complement Pathway Inhibitors (emerging drug class)
• Diagnostic Imaging Devices (OCT, fundus photography, autofluorescence imaging)
• Regenerative Medicine & Stem Cell Therapy (in research phase)
• Supportive Devices & Monitoring Tools

By Platform
• Prescription & Over-the-Counter Supplements
• Specialty Biologics & Clinical Trial Drugs
• Diagnostic & Imaging Platforms
• Research & Academic Tools

By Technology
• Optical Coherence Tomography (OCT)
• Fundus Autofluorescence (FAF) Imaging
• AI-Powered Retinal Imaging & Screening
• Gene Therapy & Stem Cell Platforms (under trial)
• Digital Health Monitoring Solutions

By End Use
• Hospitals
• Ophthalmology Clinics
• Ambulatory Care Centers
• Academic & Research Institutes

By Application
• Early-Stage Dry AMD (drusen accumulation)
• Intermediate Dry AMD (geographic atrophy risk)
• Advanced Dry AMD (vision impairment, geographic atrophy)
• Clinical Research & Experimental Trials

Summary: The Dry AMD market remains heavily weighted toward diagnostics and supportive therapies, while new complement inhibitors and regenerative solutions under clinical development are expected to expand treatment options by 2034.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72296/dry-amd-patient-pool-analysis-market

Regional Analysis
North America
• Largest share due to advanced healthcare infrastructure and high AMD awareness.
• U.S. leading in clinical trial activity for Dry AMD drug development.
• Widespread adoption of OCT and AI-powered retinal imaging.
Europe
• Germany, UK, and France at the forefront of research into complement inhibitors.
• Expanding elderly population driving significant patient pool growth.
• EU rare disease and ophthalmology funding encouraging innovation.
Asia-Pacific
• Fastest-growing region, led by Japan, China, and India.
• Rising prevalence due to demographic shifts and lifestyle risk factors.
• Expanding adoption of advanced imaging devices in urban centers.
Middle East & Africa
• GCC countries investing in retinal diagnostic infrastructure.
• Limited AMD screening programs in Africa, though urban awareness is increasing.
• Growth in medical tourism supporting specialized ophthalmic care.
Latin America
• Brazil and Mexico leading in adoption of nutritional supplements and OCT devices.
• Expanding middle-class population contributing to increased diagnosis rates.
• Ongoing research collaborations with global pharma companies.

Summary: North America and Europe dominate due to innovation and clinical research, while Asia-Pacific is the fastest-growing region, driven by demographics, awareness, and access to advanced diagnostics.

Market Dynamics
Growth Drivers
1. Expanding Elderly Populations: Higher AMD prevalence linked to aging demographics.
2. Diagnostic Advancements: OCT and AI-enhanced retinal imaging enabling early detection.
3. R&D Investment: Strong clinical trial activity for complement inhibitors and regenerative therapies.
4. Lifestyle & Preventive Approaches: Widespread use of supplements improving awareness and management.

Challenges
1. Lack of Curative Therapy: Current options only slow progression, not reverse disease.
2. Underdiagnosis: Millions remain undiagnosed, especially in developing countries.
3. Cost Barriers: Advanced therapies and diagnostics remain expensive.
4. Long-Term Trial Requirements: Clinical validation of new therapies is time-consuming.

Latest Trends
• Complement Pathway Inhibitors: Emerging as a leading drug development target.
• AI Imaging Tools: Supporting early screening and monitoring in primary care.
• Stem Cell Therapy Trials: Showing promise in regenerating retinal pigment epithelium.
• Digital Health Integration: Remote monitoring platforms aiding patient management.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72296

Competitor Analysis
Major Players:
• Novartis AG
• Apellis Pharmaceuticals
• Genentech (Roche)
• Bayer AG
• Regeneron Pharmaceuticals
• Iveric Bio (Astellas Pharma)
• Bausch + Lomb
• Opthea Limited
• AI-driven ophthalmic imaging startups (e.g., RetinAI, DeepMind collaborations)

Competitive Dynamics:
The Dry AMD market is currently diagnostics- and supplement-driven, but competition is intensifying with the development of complement inhibitors, gene therapies, and regenerative solutions. Established pharma companies dominate late-stage trials, while startups and research institutes are pushing innovation in AI diagnostics and novel treatment pathways.

Conclusion
The Dry AMD patient pool analysis market is projected to grow from USD 9.8 billion in 2024 to USD 19.2 billion by 2034, at a CAGR of ~6.9%. Growth is being fueled by rising patient prevalence, expanding diagnostic infrastructure, and strong investment in drug development pipelines.
While the lack of curative therapies and high costs remain challenges, the outlook is optimistic. The next decade will see complement inhibitors, AI-based diagnostics, and regenerative medicine reshape the Dry AMD landscape, expanding treatment opportunities and improving patient outcomes.

This report is also available in the following languages : Japanese (ドライAMD患者プール分析、市場), Korean (건성 AMD 환자 풀 분석, 시장), Chinese (干性AMD患者群体分析、市场), French (Analyse du bassin de patients atteints de DMLA sèche et du marché), German (Analyse des Patientenpools für trockene AMD, Markt), and Italian (Analisi del bacino di pazienti affetti da AMD secca, mercato), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72296

Our More Reports:

Spasticity Market
https://exactitudeconsultancy.com/reports/72074/spasticity-market

Secondary Progressive Multiple Sclerosis Market
https://exactitudeconsultancy.com/reports/72072/secondary-progressive-multiple-sclerosis-market

Primary Progressive Aphasia Market
https://exactitudeconsultancy.com/reports/72070/primary-progressive-aphasia-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dry Age-Related Macular Degeneration Patient Pool Analysis Market Projected to Grow at 6.9% CAGR here

News-ID: 4194031 • Views:

More Releases from Exactitude Consultancy

Neurotrophic Keratitis Patient Pool Analysis Market Forecast to Grow at 8.2% CAGR
Neurotrophic Keratitis Patient Pool Analysis Market Forecast to Grow at 8.2% CAG …
Introduction Neurotrophic keratitis (NK) is a rare, degenerative corneal disease caused by impaired corneal innervation, leading to reduced or absent corneal sensitivity. This results in poor wound healing, epithelial breakdown, and in severe cases, corneal ulceration, scarring, and vision loss. Although classified as a rare disease, NK has a significant clinical impact due to its association with conditions such as herpes simplex virus (HSV) keratitis, herpes zoster ophthalmicus, diabetes, ocular surgeries,
Glaucoma Market Expected to Reach USD 15.0 Billion by 2034
Glaucoma Market Expected to Reach USD 15.0 Billion by 2034
Glaucoma is a group of eye disorders characterized by progressive optic nerve damage and visual field loss, often linked to elevated intraocular pressure (IOP). It is the second leading cause of irreversible blindness worldwide, affecting millions, particularly the elderly. The most common forms include primary open-angle glaucoma (POAG) and angle-closure glaucoma, but secondary forms (due to trauma, inflammation, or steroid use) also contribute significantly. Download Full PDF Sample Copy of Market
Night Vision Disturbances Market Forecast to Grow at 6.8% CAGR
Night Vision Disturbances Market Forecast to Grow at 6.8% CAGR
Introduction Night vision disturbances (NVD) encompass a range of visual impairments that occur under low-light conditions, such as halos, glare, starbursts, and difficulty seeing in dim environments. These disturbances can be associated with refractive errors, cataracts, corneal diseases, retinal disorders, or post-surgical complications such as LASIK and intraocular lens (IOL) implantation. While often underreported, NVD significantly affects quality of life by impairing driving ability, mobility, and overall visual confidence. With global aging
Hyperopia Market is projected to reach USD 13.7 billion by 2034
Hyperopia Market is projected to reach USD 13.7 billion by 2034
Hyperopia, also known as farsightedness, is a common refractive error where distant objects are seen more clearly than near ones. It occurs due to the short axial length of the eye or abnormal corneal curvature, causing light to focus behind the retina. Symptoms include eye strain, blurred near vision, headaches, and difficulty with reading or prolonged near work. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72287 The growing global demand

All 5 Releases


More Releases for AMD

Onlive Server Brings AI-Powered AMD Dedicated Servers
We are all aware of how useful, and sometimes even crucial, proper hosting services can be for a business. That is why Onlive Server is providing this new option with the newly recommended AI-powered AMD Dedicated Server Hosting[https://onliveserver.com/amd-dedicated-server-hosting/]. Furthermore, these servers are powered by AMD technology and do superbly in servicing the tremendous demand of agile business workloads with modern AI computations, big data, and other emerging technologies. AI-powered solutions are
06-13-2024 | Health & Medicine
Fact.MR
Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry …
The Age-related Macular Degeneration Market (AMD) is poised for significant growth over the coming years, with projections indicating a compound annual growth rate (CAGR) of 6.2%, leading to an estimated market value of $20 billion by the end of the forecast period. This robust expansion is driven by several critical factors, including the rising prevalence of eye diseases, advancements in medical technology, and an aging population that is increasingly susceptible
AMD Workstations Market | BIZON, BOXX Technologies, Broadberry, Dell
The global amd workstations market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the amd workstations market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Airway Management Products (AMD) Market 2021 | Detailed Report
Airway Management Products (AMD) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5262437 The report provides a comprehensive analysis of company profiles listed below: - Medtronic - Teleflex - Ambu - Smiths Medical - Intersurgical - Becton Dickinson - Armstrong Medical - Medline Industries Airway Management Products
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
Global Microprocessor Market 2018 - Intel, Qualcomm, Apple, AMD
Apex Market Reports, recently published a detailed market research study focused on the “Microprocessor Market” across the global, regional and country level. The report provides 360° analysis of “Microprocessor Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Microprocessor on the basis of